Upcoming Medical Conferences in Bahamas

Internal Medicine for Primary Care: Endocrinology/Gastroenterology/Infectious Disease/Toxicology is organized by Medical Education Resources (MER) and will be held from Dec 05 - 08, 2019 at Atlantis Paradise Island Resort, Nassau, New Providence, Bahamas. This CME Conference has been approved for a maximum of 16 AMA PRA Category 1 Credit(s)™. Target Audience This program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine. Learning Objectives Upon completion of this program, participants should be better able to: • Discuss current diagnostic and treatment approaches to thyroid nodules and disorders • Review the diagnostic criteria and therapeutic approaches to osteoporosis and other bone-health related disorders • Identify at risk patients, institute diagnostic criteria, and manage fatty liver and celiac disease • List current treatment recommendations for celiac disease and lower GI bleeding • Describe the approach to the poisoned patient as seen in primary care • Discuss strategies to treat individuals abusing both legal and illegal substances • Diagnose and manage important infectious disease syndromes in a range of organbased systems (respiratory, gastrointestinal, skin and soft-tissue) • Identify updates for immunizations Learning Outcome To provide updates in primary care medicine to office based providers

Topics in Emergency Medicine is orgaized by Northwest Seminars (NWS) and will be held from Jan 08 - 11, 2020 at Grand Hyatt Baha Mar, Nassau, New Providence, Bahamas. Target Audience: This course is designed for physicians, physician assistants, nurse practitioners, registered nurses, and all other medical care providers who must maintain state-of-the-art knowledge of the specialty or are impacted by it.  Accreditation: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 20 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 20 hours of Category I credit for completing this program. Registered Nurses: NWS is an approved provider for the following state nursing boards: Arkansas State Board of Nursing (Provider Number 50-7480), California Board of Registered Nursing (Provider Number 4833), District of Columbia Board of Nursing (Provider Number 50-7480), Florida Board of Nursing (Provider Number 50-7480), Georgia Board of Nursing (Provider Number 50-7480), and the South Carolina Board of Nursing (Provider Number 50-7480). This program offers 20 contact hours. Course Description: The practitioner of emergency medicine must possess evidence-based scientific background for competent clinical practice; maintain state-of-the-art knowledge of the specialty and all additional related disciplines; maintain an up-to-the-minute armamentarium of knowledge and skills for the selection and use of complex equipment, pharmacological agents, and procedures; manage self and colleagues to function toward common goals in providing consistent care in all settings in which emergency care is provided; serve as an expert in matters involving quality, safe and equitable health care delivery and support of other service providers, departments, institutions, and organizations dependent upon professional expertise. Presentations are designed to facilitate the acquisition of cognitive and technical skills as defined through evidenced based data translated to best practice standards by the pertinent governmental and professional organizations including the American College of Emergency Physicians, American College of Surgeons and the Emergency Nurses Association and abilities in one or more of the disciplines vital to the practicing professional.  Course Objectives: At the conclusion of this activity, the participant will be able to: • Apply the pertinent physical and behavioral sciences as they impact and are affected by the planning, delivery, and monitoring of services inherent in the professions • Explain the selection, dosing considerations with methods of administration, safe use, contraindications and precautions of drugs based on their chemical and pharmacologic properties • Outline comprehensive patient management plans for the special patient population discussed • Apply the principles of safety and asepsis in the performance of all aspects of patient care regardless of the clinical environment in which the practice resides • Incorporate the published tenets of pertinent, recognized external organizations, institutions, and professional groups defining medical, legal, philosophical, ethical, and health care management standards.  Additional details will be posted as soon as they are available.

2020 Atlantis Foot & Ankle Symposium is organized by St. Louis Podiatry Seminar, Inc., Professional Education and Research Institute (PERI), Inc. and will be held from Jan 17 - 19, 2020 at Atlantis Bahamas, Paradise Island, New Providence, Bahamas. This course has been approved for a maximum of 21 Continuing education contact hours (CECH). Target Audience: For All Interested Podiatric Physicians Additional details will be posted as soon as information is available.

19th Annual Caribbean Dermatology Symposium is organized by Global Academy for Medical Education and will be held from Jan 21 - 25, 2020 at Atlantis Bahamas, Paradise Island, New Providence, Bahamas. This Conference is for You: • Dermatologists  • Dermatology Residents  • Family Practitioners  • Internists  • Physician Assistants  • Nurse Practitioners  • Nurses and other Healthcare Professionals Accreditation: Physicians The University of Louisville School of Medicine designates this live activity for a maximum of 20.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Nursing Education The maximum number of hours awarded for this Continuing Nursing Education activity is 20.5 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate. Description: This is an educational program led by internationally-known faculty who will provide the latest updates in medical dermatology and the diagnosis and treatment of various dermatologic conditions. Learning Objectives: At the conclusion of this live conference, participants should be better able to: • Design a comprehensive treatment plan for acne patients based on clinical guidelines, incorporating pharmacologic and nonpharmacologic strategies. • Discuss the clinical relevance of the most recent research on the etiologies and therapy of acne vulgaris. • Discuss the topical treatment pipeline for acne. • Identify patients at risk for various skin lesions, including actinic and seborrheic keratoses and nonmelanoma skin cancers. • Describe therapeutic approaches to actinic keratosis that optimize efficacy in treating lesions while reducing risk for neoplastic complications • Differentiate seborrheic keratosis from other skin lesions, particularly melanoma • Match patients with the most appropriate interventions for effective and cosmetically acceptable treatment of SK lesions. • Design evidence-based, guideline-driven treatment strategies for patients with AD based on disease severity with the goal of clear or almost clear skin. • Incorporate strategies for use of new therapies aimed at blocking the inflammatory mediators of AD. • Identify which allergens are likely to be problematic for patients with atopy and integrate patch testing when appropriate • Discuss the risks and benefits of CAR-T cell therapy in melanoma. • Differentiate among potential causes of contact dermatitis and the treatment approaches required. • Explain the multiple entities that are encompassed by the umbrella term “toxic erythema of chemotherapy” (TEC). • Discuss the prevention and management of cutaneous AEs associated with chemotherapies and radiation therapy. • Discuss basic approaches to perform a nail unit biopsy. • Discuss surgical approaches to treating rhinophyma. • Incorporate simple surgical tips for large wounds, wound under tension, or to increase efficiency and patient satisfaction. • Apply basic dermoscopy to the assessment of skin lesions. • Incorporate newer dermoscopy imaging technologies in clinical practice. • Describe evidence-based strategies for the diagnosis and pharmacologic management of hyperhidrosis. • Describe the data on the new topical anticholinergic agents in the management of hyperhidrosis. • Distinguish key characteristics of emerging and newly approved agents for treating skin infections such as ABSSTI (acute bacterial skin and soft tissue infections). • Distinguish malignant from nonmalignant suspicious neoplasms. • Design a management plan for melanomas at all stages of development. • Design treatment strategies appropriate for pediatric patients with common dermatologic conditions • Identify characteristics in pediatric patients that suggest increased risk for conversion of benign moles to dysplastic nevi or melanoma • Describe characteristics of IHs that are more likely to require medical intervention. • Identify how to diagnose and treat common pediatric hair diseases. • Differentiate the various photodermatoses from other dermatologic conditions whose symptoms manifest in similar ways. • Describe the algorithm for the diagnosis of photodermatoses. • Discuss photoprotection with patients, including pediatric patients and their caregivers. • Describe the pathophysiology of psoriasis and its associated comorbidities. • Diagnose and treat patients with psoriasis appropriately, based on current clinical guidelines. • Design treatment strategies that incorporate biologic therapies into the management of appropriately selected patients with psoriasis. • Increase routine screening for psoriatic arthritis in patients with psoriasis. • Design self-education and patient education programs as part of the treatment plan for rosacea treatment. • Discuss appropriate treatment strategies for rosacea, based on individual signs and symptoms as well as knowledge of the indications, efficacy, and risks of available and emerging rosacea therapies. • Describe the presentation, diagnosis and management of common tropical diseases. Optional Workshop : Dermoscopy from A-Z Friday, January 24, 2020

Imaging in the Bahamas Course is organized by CME Science and will be held from Feb 03 - 06, 2020 at Grand Hyatt Baha Mar, Nassau, New Providence, Bahamas. Target Audience: The course is intended for practicing radiologists and radiologic nurses, physician assistants, technologists, scientists, residents, fellows and others who are interested in current techniques and applications for advanced diagnostic imaging.JK Accreditation Statement: Physician Continuing Medical Education: The Postgraduate Institute for Medicine designates this live activity for a maximum of 18.0 AMA PRA Category 1 Credit(s)™. Technologists: This course is pending approval for up to 18.0 ARRT Category A CE credits SAM Credit: This course is approved for 8 SAM Credits. Additional SAM Credit Pending Objectives: The Imaging in Bahamas course is designed to provide the tools for participants to enhance interpretation skills utilizing the latest imaging technologies. Lectures and cases will cover evidence-based practice techniques and protocols for improved diagnostic accuracy in multiple applications. At the conclusion of this activity, participants should be able to: • Describe the common challenges in interpreting PET/CT. • Optimize Abdominal Imaging Methods. • Explain the performance and processing of MRI and CT studies designed to depict anatomy and pathology. • Use contemporary imaging techniques and protocols to accurately diagnose, stage and manage diseases and injuries of the musculoskeletal system. • Develop differential diagnosis that relates to the pertinent imaging and clinically relevant findings for each of the cases covered in this course. • Outline the fundamentals of the latest advanced techniques in MRI and CT and their current roles and limitations in clinical practice. • Integrate information presented in this course into efforts to improve the imaging skills of the participants. Time: 7:00 am to 12:00 pm

Internal Medicine for Primary Care: Allergy & Immuno/Gyn/Neuro/Ortho is organized by Medical Education Resources (MER) and will be held from Feb 06 - 09, 2020 at Atlantis Bahamas, Nassau, New Providence, Bahamas. This CME Conference has been approved for a maximum of 16 Credit Hours. Early Bird Physician Fee - $ 995 Early Bird Non-Physician - $ 895 Additional details will be posted as soon as they are available.

4th DNA Repair/Replication Structures and Cancer Conference is organized by Fusion Conferences Ltd and will be held from Feb 16 - 20, 2020 at Melia Nassau Beach All Inclusive, Nassau, New Providence, Bahamas. Synopsis: The 4th DNA Repair/Replication Structures & Cancer conference in February 2020 will focus on structural and mechanistic insights into dynamic protein, chromatin, DNA and RNA complexes acting in DNA repair and its interface with DNA replication and transcription events relevant to cancer. This fundamental information will be pivotal for the accurate interpretation of cancer clinical data, design of clinical trials, prognosis, etiology and improving the currently 1/20 low success rate for oncology drug clinical trials. Informative talks and poster sessions along with vibrant discussions will foster productive interactions and collaborations. Key Sessions: Sessions will include emerging results and breakthrough methods concerning: • Repair and replication complexes, structures and mechanisms. • RNA damage responses and actions in repair. • Mutational signatures, DNA repair, and cancer. • Intertwined interactions in transcription-replication-repair. • Damage signaling, pathway selection & cross-talk. • Targeting synthetic lethality and essentiality for damage responses. • Chromatin and chromosome instability. • Epigenetics, DNA damage and repair. • PARP, PARG, and metabolic signaling. • Mitochondrial replication/repair and damage signaling. • DNA repair, apoptosis and cancer. Additional details will be posted as soon as they are available.

35th Annual Series: Emergency Medicine & Acute Care 2020 - A Critical Appraisal is organized by The Center for Medical Education, Inc. and will be held from Feb 17 - 21, 2020 at Atlantis Bahamas, Nassau, New Providence, United States of America. This Conference has been approved for a maximum of 20 AMA PRA Category 1 Credit™. Join Us for a Focused, Evidence-Based Course That’s Designed to Update You on Over 32 Leading Edge Topics. Serious CME | Top Destinations | Prime Times You’ll experience an engaging, no-fluff, fast-paced, update of the literature surrounding key emergency medicine topics by an experienced, energetic faculty of emergency medicine educators. Now Using Both EM:RAP’s Emergency Medical Abstracts and CorePendium The Emergency Medicine & Acute Care Course is now collaborating with EM:RAP and will be using as its sources EM:RAP’s Emergency Medical Abstracts and the newly released (October, 2019) CorePendium. Since 1977, Emergency Medical Abstracts has been searching hundreds of journals and providing audio summaries of the most important papers in emergency medicine. CorePendium is a new internet-based comprehensive multimedia text specifically focusing on emergency medicine that is literature-based and updated every three months with the latest information from the medical literature. Target Audience: The target audience for this course is physicians, PAs and NPs who practice in emergency departments and are seeking an evidence-based, literature-focused update in controversial areas of emergency care. Learning Objectives: After attending this course, participants will be able to: • Discuss key points from the literature regarding leading-edge Emergency Medicine topics • Discuss literature-based recommendations for practice improvement • Effectively translate the acquired strategies into improved diagnostics and subsequently implement a better treatment plan for their patients Topics: • Dizzy Patients – Is It Posterior Fossa? • Syncope: Don’t Screw It Up • No More LPs in Kids Age 29-60 Days? • UTIs in Toddlers, Overdiagnosed? • Treating Benign Vomiting / Diarrhea in Kids • Can You Blame Otitis Media for a Fever? • Atrial Fibrillation – Lots to Know - Part 1 • Atrial Fibrillation – Lots to Know - Part 2 • Pharyngitis – Still Figuring It Out in 2020 • Clinical Pneumonia / Negative CXR? • Myths in Emergency Medicine • The Top 8 Malpractice Diagnoses - Part 1 • The Top 8 Malpractice Diagnoses - Part 2 • US vs Chest X-ray vs CT? • Sexual / Ethnic / Racial Bias in EM • Pearls from Risk Management Monthly • Pearls from ED Leadership Monthly • Still Prescribing Fluoroquinolones? • Who Needs a CTCA in the ED? • Outpatient Orthopedics Pearls • New ED Guidelines to Know About - Part 1 • New ED Guidelines to Know About - Part 2 • Psychiatric Patients – Big Time Risks • DKA in Kids and Adults – Leading Edge • Trauma Care Controversies • ED Boarding is Very Bad for Patients! • Visual Diagnosis Challenges - Part 1 • Visual Diagnosis Challenges - Part 2 • Important Recent EM Literature - Part 1* • Important Recent EM Literature - Part 2* • Optimizing ED Operations* • Diagnostic and Therapeutic Controversies* *Topics listed with an asterisk (*) are 90-minute faculty panel discussions; all other topics are 30 minutes. Topics subject to change without notice.

2nd DNA and Interacting Proteins as Single Molecules - In Vitro and In Vivo Conference is organized by Fusion Conferences Ltd and will be held from Feb 20 - 23, 2020 at Melia Nassau Beach All Inclusive, Nassau, New Providence, Bahamas. Target Audience: Researchers interested in the study of DNA metabolic events at the single molecule level: both in vitro and in vivo. Processes to be focused on – DNA replication, DNA recombination, DNA repair and transcription. In addition, single cell sequencing/genomics groups will also be targeted. Synopsis: The advent of single-molecule approaches has revolutionized our understanding of Molecular Biology. Combined advances in light microscopy, microfluidics, atomic force microscopy, and DNA sequencing have opened ways to bypass population averages and study individual molecular events for a variety of cellular processes. This meeting aims to present the most recent advances in the mechanistic understanding of DNA metabolic processes at the single-molecule level, using both in vivo and in vitro approaches. Sessions will cover various aspects of: • DNA replication • DNA recombination • DNA repair • Transcription • Chromosome dynamics • Genomics Each session will be divided into in vitro and in vivo sections to highlight differences and complementary information obtained. Educational Need: The single molecule field initially focused on experiments done in vitro. As the field has evolved and new technologies were developed, the understanding of single molecule behaviour in live cells has become increasingly important. The two fields have developed largely separately and by combining these into a single meeting will educate scientists on the value of and difficulties associated with both approaches to understanding key elements in genome maintenance, and the passage of genetic information from DNA to protein.

2nd Nuclear Receptors Conference is organized by Fusion Conferences Ltd and will be held from Feb 24 - 27, 2020 at Melia Nassau Beach Hotel, Nassau, New Providence, Bahamas. Target Audience: Scientists and Clinician Scientists at a range of levels from postdoctoral and up: Principal Investigators, Junior Team Leaders, Research Fellows. Ambitious postgraduate students in the field will also be encouraged to attend. Relevant specialties are wide-ranging, reflecting the importance of nuclear receptors in many aspects of health and disease. These include Endocrinology, Oncology, Paediatrics, Urology, Gynaecology, Obstetric Medicine, Neuroscience, Cardiology. Description: This meeting will address the new roles and novel crosstalk mechanisms that are emerging for many of the 48 human nuclear receptors, in health and disease. For example, it has long been known that the estrogen receptor drives progression of breast cancer, and patients with estrogen receptor-positive disease are treated using antiestrogens or aromatase inhibitors to inhibit estrogen signalling. Now however, it is apparent that the androgen receptor can in some cases drive breast cancer progression and is a therapeutic target, resulting in clinical trials for androgen receptor-targeting therapies in advanced breast cancer. The androgen receptor, itself long the main therapeutic target in prostate cancer, is emerging as a key player in metabolic disease, while conversely other nuclear receptor including the glucocorticoid receptor and several orphan nuclear receptors are implicated in prostate cancer progression. Meanwhile, given the impact of many nuclear receptors on the central nervous system, it is unsurprising that they are being explored in the context of neurological disorders and depression. Thus there is wide scope for re-purposing of licensed drugs and development of new NR-targeting therapies for a host of conditions and diseases. This unique meeting will bring together many of the leading figures in nuclear receptor research from across the globe, to discuss emerging roles and their implications for health and disease - and both human and drug development - in an intimate meeting that will generate meaningful idea exchange and interaction that will help to further shape this influential field. Key Sessions: • Further emerging roles for nuclear receptors in cancer • Structural insights into nuclear receptor function and crosstalk • Nuclear receptors’ role in epigenetic regulation and non coding RNA • Nuclear receptors and DNA damage • Nuclear receptors and cell cycle • Nuclear receptors in metabolism/metabolic disease • Nuclear receptors in the CNS Additional details will be posted as soon as they are available.